Diabetes drug maker Novo Nordisk buys pill factory in North Carolina

Date Published08/06/2019
Author NameJacob Gronholt-Pedersen
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Novo Nordisk
Parent companyNovo Nordisk
Type of work Manufacturing
Reshoring category:Foreign Direct Investment
Year reshoring announced:2019
Country(ies) from which reshored:Denmark
City reshored to:Treyburn
State(s) reshored to:NC
If relevant, work nearshored to:-
Product(s) reshorednew diabetes drug
What domestic positive factors made reshoring more attractive?Proximity to customers/market, Under-utilized capacity
Find Reshoring Articles